Assignee
CV THERAPEUTICS INC
US·100 granted patents·10 pending applications·2,808 citations·filing 1994–2008
Top patents by PatentIndex Score
110 records- 0198US7144872B2N-pyrazole A2A receptor agonistsCV THERAPEUTICS INC·Filed 2005·Granted Dec 5, 2006·50 cites·27 claims
- 0297US7553823B2C-pyrazole A2A receptor agonistsCV THERAPEUTICS INC·Filed 2006·Granted Jun 30, 2009·48 cites·8 claims
- 0396US7183264B2N-pyrazole A2A receptor agonistsCV THERAPEUTICS INC·Filed 2003·Granted Feb 27, 2007·48 cites·22 claims
- 0496US6825349B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2002·Granted Nov 30, 2004·95 cites·31 claims
- 0596US6642210B12-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonistsCV THERAPEUTICS INC·Filed 2000·Granted Nov 4, 2003·61 cites·18 claims
- 0696US6552023B2Aralkyl substituted piperazine compoundsCV THERAPEUTICS INC·Filed 2001·Granted Apr 22, 2003·64 cites·24 claims
- 0796US6548548B2ABCA-1 elevating compoundsCV THERAPEUTICS INC·Filed 2001·Granted Apr 15, 2003·61 cites·39 claims
- 0896US6403567B1N-pyrazole A2A adenosine receptor agonistsCV THERAPEUTICS INC·Filed 1999·Granted Jun 11, 2002·112 cites·13 claims
- 0995US7317017B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2005·Granted Jan 8, 2008·22 cites·15 claims
- 1095US7109180B2C-pyrazole A2A receptor agonistsCV THERAPEUTICS INC·Filed 2004·Granted Sep 19, 2006·43 cites·8 claims
- 1195US6770634B1C-pyrazole a2a receptor agonistsCV THERAPEUTICS INC·Filed 2000·Granted Aug 3, 2004·46 cites·6 claims
- 1295US6677336B2Substituted piperazine compoundsCV THERAPEUTICS INC·Filed 2001·Granted Jan 13, 2004·59 cites·34 claims
- 1395US6573264B1Heteroaryl alkyl piperazine derivativesCV THERAPEUTICS INC·Filed 2000·Granted Jun 3, 2003·60 cites·41 claims
- 1494US7160592B2Polymer coating for medical devicesCV THERAPEUTICS INC·Filed 2003·Granted Jan 9, 2007·211 cites·51 claims
- 1594US6977300B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2003·Granted Dec 20, 2005·69 cites·25 claims
- 1694US6852724B2Sustained release ranolazine formulationsCV THERAPEUTICS INC·Filed 2003·Granted Feb 8, 2005·37 cites·17 claims
- 1794US6677342B2Partial fatty acid oxidation inhibitors in the treatment of congestive heart failureCV THERAPEUTICS INC·Filed 2002·Granted Jan 13, 2004·72 cites·20 claims
- 1894US6525057B2Sustained release ranolazine formulationsCV THERAPEUTICS INC·Filed 2001·Granted Feb 25, 2003·44 cites·12 claims
- 1994US6479496B1Methods for treating angina with ranolazineCV THERAPEUTICS INC·Filed 2000·Granted Nov 12, 2002·55 cites·10 claims
- 2094US5866702APurine inhibitors of cyclin dependent kinase 2CV THERAPEUTICS INC·Filed 1996·Granted Feb 2, 1999·142 cites·6 claims
- 2193US7582617B2Myocardial perfusion imaging methodCV THERAPEUTICS INC·Filed 2005·Granted Sep 1, 2009·27 cites·22 claims
- 2293US6794390B2Purine inhibitors of cyclin dependent kinase 2 & ikappabalphaCV THERAPEUTICS INC·Filed 2001·Granted Sep 21, 2004·43 cites·11 claims
- 2393US6620814B2Sustained release ranolazine formulationsCV THERAPEUTICS INC·Filed 2002·Granted Sep 16, 2003·35 cites·27 claims
- 2493US6617328B2Sustained release ranolazine formulationsCV THERAPEUTICS INC·Filed 2002·Granted Sep 9, 2003·32 cites·33 claims
- 2593US6605597B1Partial or full A1agonists-N-6 heterocyclic 5′-thio substituted adenosine derivativesCV THERAPEUTICS INC·Filed 1999·Granted Aug 12, 2003·97 cites·13 claims
- 2693US6503911B2Sustained release ranolazine formulationsCV THERAPEUTICS INC·Filed 2001·Granted Jan 7, 2003·36 cites·9 claims
- 2793US6369062B1Sustained release ranolazine formulationsCV THERAPEUTICS INC·Filed 2000·Granted Apr 9, 2002·37 cites·1 claims
- 2892US6451798B2Substituted alkyl piperazine derivativesCV THERAPEUTICS INC·Filed 2001·Granted Sep 17, 2002·26 cites·26 claims
- 2992US6294522B1N6 heterocyclic 8-modified adenosine derivativesCV THERAPEUTICS INC·Filed 1999·Granted Sep 25, 2001·122 cites·24 claims
- 3092US6214807B1C-pyrazole 2A A receptor agonistsCV THERAPEUTICS INC·Filed 1999·Granted Apr 10, 2001·74 cites·33 claims
- 3191US7125993B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2003·Granted Oct 24, 2006·37 cites·47 claims
- 3291US6946449B2Partial and full agonists of A1 adenosine receptorsCV THERAPEUTICS INC·Filed 2002·Granted Sep 20, 2005·26 cites·30 claims
- 3391US6562826B1Sustained release ranolazine formulationsCV THERAPEUTICS INC·Filed 2002·Granted May 13, 2003·31 cites·26 claims
- 3491US6075150Aα-ketoamide inhibitors of 20S proteasomeCV THERAPEUTICS INC·Filed 1998·Granted Jun 13, 2000·96 cites·2 claims
- 3591US5789416AN6 mono heterocyclic substituted adenosine derivativesCV THERAPEUTICS INC·Filed 1996·Granted Aug 4, 1998·107 cites·14 claims
- 3690US6303607B1Method for administering a sustained release ranolanolazine formulationCV THERAPEUTICS INC·Filed 1999·Granted Oct 16, 2001·53 cites·2 claims
- 3788US7713946B2Partial and full agonists A1 adenosine receptorsCV THERAPEUTICS INC·Filed 2006·Granted May 11, 2010·12 cites·19 claims
- 3887US7521554B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2006·Granted Apr 21, 2009·7 cites·5 claims
- 3987US7479485B2Method of treating arrhythmiasCV THERAPEUTICS INC·Filed 2005·Granted Jan 20, 2009·5 cites·5 claims
- 4087US6599283B1Method of preventing reperfusion injuryCV THERAPEUTICS INC·Filed 2001·Granted Jul 29, 2003·53 cites·10 claims
- 4186US7419709B2Polymer coating for medical devicesCV THERAPEUTICS INC·Filed 2006·Granted Sep 2, 2008·12 cites·5 claims
- 4286US7364768B2Polymer coating for medical devicesCV THERAPEUTICS INC·Filed 2006·Granted Apr 29, 2008·14 cites·15 claims
- 4386US7304070B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2004·Granted Dec 4, 2007·23 cites·36 claims
- 4486US6818647B2Method and composition for restoring diuretic and renal functionCV THERAPEUTICS INC·Filed 2002·Granted Nov 16, 2004·16 cites·19 claims
- 4586US6528511B2Partial fatty acid oxidation inhibitors in the treatment of congestive heart failureCV THERAPEUTICS INC·Filed 2001·Granted Mar 4, 2003·22 cites·35 claims
- 4685US7271157B2A1 adenosine receptor agonistsCV THERAPEUTICS INC·Filed 2005·Granted Sep 18, 2007·7 cites·29 claims
- 4784US6821774B1Compositions and methods for increasing cholesterol efflux and raising HDL using ATP binding cassette transporter ABC1CV THERAPEUTICS INC·Filed 2000·Granted Nov 23, 2004·12 cites·9 claims
- 4884US6677343B2Substituted piperazine compoundsCV THERAPEUTICS INC·Filed 2001·Granted Jan 13, 2004·15 cites·25 claims
- 4984US6440948B1Thiophene A2A receptor agonistsCV THERAPEUTICS INC·Filed 2000·Granted Aug 27, 2002·19 cites·16 claims
- 5083US6900219B2ABCA-1 elevating compoundsCV THERAPEUTICS INC·Filed 2003·Granted May 31, 2005·23 cites·48 claims
Showing the top 50 of 110 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CV THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →